Table 2

Change from baseline in homodynamic, arterial stiffness and metabolic variables in each group

Variables

Patients received antioxidants

Patients received placebo


baseline

6 month

p-value

baseline

6 month

p-value


Systolic BP (mm/Hg)

145.2 ± 25.4

136.1 ± 22.3

0.001

138.0 ± 20.8

135.0 ± 21.6

0.257


Diastolic BP (mm/Hg)

78.4 ± 11.7

75.0 ± 12.3

0.034

75.9 ± 7.8

75.0 ± 10.3

0.493


LAEI(ml/mm Hg × 10)

11.0 ± 4.4

12.7 ± 4.7

0.006

12.9 ± 6.2

11.3 ± 4.3

0.151


SAEI(ml/mm Hg × 100)

3.3 ± 1.9

4.7 ± 2.7

0.0001

3.6 ± 1.6

3.7 ± 1.9

0.732


SVR(dynes•sec/cm5)

1817.0 ± 751.5

1617.3 ± 305.2

0.102

1594.9 ± 351.3

1638.7 ± 311.3

0.533


Glucose(mg/dl)

127.0 ± 52

129 ± 62

0.535

118.9 ± 42

123.2 ± 55

0.496


HbA1C(%)

7.08 ± 1.69

6.33 ± 2.3

0.022

6.82 ± 1.44

6.86 ± 1.66

0.767


Total Cholesterol(mg/dl)

201.5 ± 53.1

180.7 ± 58.3

0.074

197.12 ± 50

186.80 ± 37.78

0.125


Triglycerides(mg/dl)

189 ± 94

170.4 ± 72

0.058

124.5 ± 56.5

127.83 ± 46.7

0.645


HDL%

22.1 ± 4

26.2 ± 10

0.022

26 ± 5.4

27.11 ± 5.5

0.212


LDL Cholesterol(mg/dl)

116.8 ± 44.4

103.4 ± 47

0.13

117.91 ± 47.9

109.0 ± 33.1

0.135


hs-CRP(mg/dl)

1.94 ± 3

0.62 ± 0.77

0.222

1.44 ± 1.59

0.95 ± 0.90

0.271


Renin (ng/ml/hr)

1.79 ± 3.4

2.27 ± 2.6

0.494

1.36 ± 1.55

1.91 ± 1.87

0.149


Aldosterone(pg/ml)

7.38 ± 5.6

8.2 ± 5.06

0.354

6.70 ± 4.5

7.00 ± 3.84

0.638


Homocysteine(μmol/l)

9.24 ± 2.82

9.19 ± 2.83

0.911

8.75 ± 3.04

9.11 ± 3.3

0.139


Ur cathacholamines(mg/24 h)

24.74 ± 21

28.5 ± 19

0.118

19.54 ± 12

22 ± 20

0.283



Shargorodsky et al. Nutrition & Metabolism 2010 7:55   doi:10.1186/1743-7075-7-55

Open Data